Why reconsider the chair?
Because the option to choose home dialysis, like PD, is beneficial to patients and supported by outcomes. Changes in reimbursement policy make home programs more viable than ever for dialysis facilities and nephrologists. These facts are important in light of current trends in End-Stage Renal Disease (ESRD).
There is a solution that benefits payers, providers and patients: Peritoneal Dialysis (PD). The new Centers for Medicare and Medicaid Services reimbursement bundle no longer penalizes PD for being a lower-cost therapy. Kidney Disease Education (KDE) will be reimbursable at earlier stages. And outcomes for PD patients continually improve year after year. Shifting patients home on PD could:
Home dialysis is beneficial for patients and supported by outcomes.